497
+
contracted medical institutions
1100
+
Inspection and testing services
9000
㎡
R&D Base
Technology Enabling Precision Medical Service
The Institute was established in June 2018 under the guidance of Chongqing Science and Technology Bureau, Dadukou District Party Committee, and District Government and District Science and Technology Bureau. It focuses on researching and developing new technology and transforming industries in the field of precision medicine. Since its establishment, the government has provided significant care and support to the institute.
Numerous invention patents have been authorized. Multiple medical device registration certificates have been approved and utilized in production.
More than 20 patents have been approved and 7 are currently being declared.
Nearly 100 registration certificates for medical devices have been approved, with 14 new applications currently being processed.
To establish a cutting-edge national precision medical service complex
By establishing strong collaborations with renowned research institutions both domestically and internationally, we aim to advance technology research and development and promote industrial transformation in the precision medicine field. Our focus lies in attracting high-level entrepreneurial talents and projects from overseas, as well as nurturing exceptional domestic innovative projects. Through these efforts, we strive to enhance the precision medicine industry and establish a comprehensive research and development institution that encompasses production, education, research, business, government, and investment. Our ultimate goal is to conduct cutting-edge basic research in precision medicine and create a future-oriented innovation platform.
Efficient and accurate platform for detecting scientific research
To offer medical researchers a comprehensive platform service for the combined detection application and basic research of multi-omics, spanning from screening to verification. At present, the cell experiment platform, animal experiment platform, molecular detection platform, pathological experiment platform, multi-omics joint analysis platform, high-throughput/single cell sequencing platform, molecular affinity detection and clinical big data analysis platform have been built. Can provide perfect technical support and testing services
